Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Renée Bultijnck
Profile
Projects
Publications
Activities
Awards & Distinctions
45
Results
2024
Androgen deprivation therapy in advanced prostate cancer : insights from a real-world patient survey on health-related quality of life and information and communication sources
Renée Bultijnck
Luc De Laere
Rony De Grande
Thijs Develter
Sophie Vantieghem
Pieter Uvin
Christophe Ghysel
Bram De Laere
[missing] the patient organization Think Blue Vlaanderen vzw
A1
Journal Article
in
QUALITY OF LIFE RESEARCH
2024
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy : real-world data from the E2-RADIatE OligoCare cohort
Renée Bultijnck
Mieke Van Hemelrijck
Valerie Fonteyne
Lorenzo Livi
Barbara Alicja Jereczek-Fossa
Hossein Hemmatazad
Michael Mayinger
Heike Peulen
Luc Verbeke
Sara Ramella
et al.
A1
Journal Article
in
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY
2024
Improving completion rates of patient-reported outcome measures in cancer clinical trials : scoping review investigating the implications for trial designs
Lotte van der Weijst
Abigirl Machingura
Ahu Alanya
Emma Lidington
Galina Velikova
Hans-Henning Flechtner
Heike Schmidt
Jens Lehmann
John K. Ramage
Jolie Ringash
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2024
Nonpharmacological interventions for managing the dyspnea-fatigue-physical/role functioning symptom cluster in lung cancer patients : a systematic review
Clara Leyns
Cassandra Van Boterdael
Ellen Baele
Lindsay Poppe
Charlotte Billiet
Renée Bultijnck
Maarten Lambrecht
Yolande Lievens
Elke Rammant
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER CARE
2024
PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial
Piet Ost
Shankar Siva
Sigmund Brabrand
Piet Dirix
Nick Liefhooghe
François-Xavier Otte
Alfonso Gomez-Iturriaga
Wouter Everaerts
Mohamed Shelan
Antonio Conde-Moreno
et al.
A1
Journal Article
in
EUROPEAN UROLOGY ONCOLOGY
2024
2023
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study
Philipp Heumann
Miguel E. Aguado-Barrera
Barbara Avuzzi
David Azria
Erik Briers
Renée Bultijnck
Ananya Choudhury
Dirk De Ruysscher
Marie-Pierre Farcy-Jacquet
Valerie Fonteyne
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2023
Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data : dosimetry, acute and two years physician and patient-reported outcomes
Vincent Vakaet
Pieter Deseyne
Renée Bultijnck
Giselle Post
Catharine West
David Azria
Celine Bourgier
Marie-Pierre Farcy-Jacquet
Barry Rosenstein
Sheryl Green
et al.
A1
Journal Article
in
ACTA ONCOLOGICA
2023
Experiences of men with prostate cancer participating in a clinical pathway with a supervised group-based exercise program to combat androgen deprivation-induced side effects : a qualitative focus group study
Renée Bultijnck
Elke Rammant
ANNELEEN RAES
Nathalie Vandecasteele
Karel Decaestecker
Valerie Fonteyne
Nicolaas Lumen
Piet Ost
Benedicte Deforche
A1
Journal Article
in
SEMINARS IN ONCOLOGY NURSING
2023
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer
Harkeran K. Jandu
Colin D. Veal
Laura Fachal
Craig Luccarini
Miguel E. Aguado-Barrera
Manuel Altabas
David Azria
Adinda Baten
Celine Bourgier
Renée Bultijnck
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2023
Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types
Elnaz Naderi
Miguel E Aguado-Barrera
Line M H Schack
Leila Dorling
Tim Rattay
Laura Fachal
Holly Summersgill
Laura Martínez-Calvo
Ceilidh Welsh
Tom Dudding
et al.
A2
Journal Article
in
JNCI CANCER SPECTRUM
2023
Patient-reported outcomes and functional exercise capacity in a real-life setting in non-small cell lung cancer patients undergoing stereotactic body radiotherapy : the Lung PLUS study
Lotte van der Weijst
Renée Bultijnck
Axel Van Damme
Vincent Huybrechts
Marc Van Eijkeren
Yolande Lievens
A1
Journal Article
in
FRONTIERS IN ONCOLOGY
2023
Vaginal morbidity, sexual functioning, and health-related quality of life in cervical cancer survivors : a cross-sectional multicenter study (VAMOS)
Eline Naert
Alexander Decruyenaere
Renée Bultijnck
Emiel De Jaeghere
Marjolein Orije
Rawand Salihi
Hans Verstraelen
Philippe Tummers
Hannelore Denys
Katrien Vandecasteele
A1
Journal Article
in
SUPPORTIVE CARE IN CANCER
2023
2022
A review of the content and psychometric properties of cancer-related fatigue (CRF) measures used to assess fatigue in intervention studies
Rachel Campbell
Renée Bultijnck
Gemma Ingham
Chindhu Shunmuga Sundaram
Joshua F. Wiley
Jasmine Yee
Haryana M. Dhillon
Joanne Shaw
A1
Journal Article
in
SUPPORTIVE CARE IN CANCER
2022
Bone health and therapeutic agents in advanced prostate cancer
Maria Antonia Gómez-Aparicio
Fernando López-Campos
Lira Pelari-Mici
David Buchser
Jorge Pastor
Xavier Maldonado
Juan Zafra
Alison C. Tree
Renée Bultijnck
Paul Sargos
et al.
A1
Journal Article
in
FRONTIERS IN BIOSCIENCE-LANDMARK
2022
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer
Nuradh Joseph
Alessandro Cicchetti
Alan McWilliam
Adam Webb
Petra Seibold
Claudio Fiorino
Cesare Cozzarini
Liv Veldeman
Renée Bultijnck
Valerie Fonteyne
et al.
A1
Journal Article
in
FRONTIERS IN ONCOLOGY
2022
Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer : analysis of STOMP and ORIOLE trials
MP Deek
K Van der Eecken
P Sutera
RA Deek
Valerie Fonteyne
AA Mendes
Karel Decaestecker
AP Kiess
Nicolaas Lumen
R Phillips
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2022
Optimizing rehabilitation interventions in men with prostate cancer receiving androgen deprivation therapy
Renée Bultijnck
Piet Ost
Benedicte Deforche
Dissertation
2022
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)
Lotte van der Weijst
Miguel E. Aguado-Barrera
David Azria
Patrick Berkovic
Pierre Boisselier
Erik Briers
Renée Bultijnck
Patricia Calvo-Crespo
Jenny Chang-Claude
Ananya Choudhury
et al.
A1
Journal Article
in
LUNG CANCER
2022
Physical activity and health-related quality of life from diagnosis to one year after radical cystectomy in patients with bladder cancer : a longitudinal cohort study
Elke Rammant
Ann Van Hecke
Jelle Van Cauwenberg
Karel Decaestecker
Lindsay Poppe
Beth Russel
Renée Bultijnck
Maarten Albersen
Sofie Verhaeghe
Mieke Van Hemelrijck
et al.
A1
Journal Article
in
BLADDER CANCER
2022
Predicting patient-reported symptom clusters in prostate cancer patients : a machine learning approach
Elke Rammant
Emile Deman
Lindsay Poppe
Renée Bultijnck
P. Dirix
G. De Meerleer
K. Haustermans
Ann Van Hecke
D. Azria
J. Chang-Claude
et al.
C3
Conference
2022
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients : results of the REQUITE study
Lotte van der Weijst
David Azria
Patrick Berkovic
Pierre Boisselier
Erik Briers
Renée Bultijnck
Jenny Chang-Claude
Ananya Choudhury
Gilles Defraene
Sylvian Demontois
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2022
Treatment time and circadian genotype interact to influence radiotherapy side-effects : a prospective European validation study using the REQUITE cohort
Adam J. Webb
Emily Harper
Tim Rattay
Miguel E. Aguado-Barrera
David Azria
Celine Bourgier
Muriel Brengues
Erik Briers
Renée Bultijnck
Jenny Chang-Claude
et al.
A1
Journal Article
in
EBIOMEDICINE
2022
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
Sarah L. Kerns
Ashley Amidon Morlang
Sharon M. Lee
Derick R. Peterson
Brian Marples
Hong Zhang
Kevin Bylund
Doug Rosenzweig
William Hall
Kim De Ruyck
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2022
2021
Development of a pre‐ and postoperative physical activity promotion program integrated in the electronic health system of patients with bladder cancer (The POPEYE study) : an intervention mapping approach
Elke Rammant
Benedicte Deforche
Ann Van Hecke
Sofie Verhaeghe
BARBARA VAN RUYMBEKE
Renée Bultijnck
Mieke Van Hemelrijck
Louis Fox
Ronny Pieters
Karel Decaestecker
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER CARE
2021
Exercise prescription dose for castrate-resistant prostate cancer patients : a phase I prescription dose escalation trial
Renée Bultijnck
Benedicte Deforche
Noëmi Borrey
Jörgen Van Bauwel
Maarten Lievens
Elke Rammant
Valerie Fonteyne
Karel Decaestecker
Adelheid Steyaert
Nicolaas Lumen
et al.
A1
Journal Article
in
WORLD JOURNAL OF UROLOGY
2021
Impact of evaluation-decision form in lung cancer patients receiving stereotactic body radiotherapy
Renée Bultijnck
Axel Van Damme
Frederik Vanhoutte
Elhaseen Elamin
Katrien Vandecasteele
Patrick Berkovic
Marc Van Eijkeren
Yolande Lievens
C3
Conference
2021
The use of theory to develop physical activity interventions in urological cancer survivors : a narrative review
Elke Rammant
Renée Bultijnck
Cristina M. Caperchione
Linda Trinh
Research collaboration group of the cancer prevention and management Special Interest Group of ISBNPA
A1
Journal Article
in
SEMINARS IN ONCOLOGY NURSING
2021
2020
A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer
Elise De Bleser
Ruben Willems
Karel Decaestecker
Lieven Annemans
Aurélie De Bruycker
Valerie Fonteyne
Nicolaas Lumen
Filip Ameye
Ignace Billiet
Steven Joniau
et al.
A1
Journal Article
in
CANCERS
2020
External validation of a predictive model for acute skin radiation toxicity in the REQUITE Breast Cohort
Tim Rattay
Petra Seibold
Miguel E. Aguado-Barrera
Manuel Altabas
David Azria
Gillian C. Barnett
Renée Bultijnck
Jenny Chang-Claude
Ananya Choudhury
Charlotte E. Coles
et al.
A1
Journal Article
in
FRONTIERS IN ONCOLOGY
2020
Health-related quality of life after accelerated breast irradiation in five fractions : a comparison with fifteen fractions
Hans Van Hulle
Vincent Vakaet
Renée Bultijnck
Pieter Deseyne
Max Schoepen
ANNICK VAN GREVELING
Giselle Post
Wilfried De Neve
Christel Monten
Yolande Lievens
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2020
Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer : an umbrella review
Elke Rammant
Lisa Van Wilder
Mieke Van Hemelrijck
Nele Pauwels
Karel Decaestecker
Charles Van Praet
Renée Bultijnck
Piet Ost
Thomas Van Vaerenbergh
Sofie Verhaeghe
et al.
A1
Journal Article
in
QUALITY OF LIFE RESEARCH
2020
2019
Implementation of a lifestyle‐based clinical pathway in daily clinical practice in men undergoing androgen deprivation therapy for prostate cancer
Renée Bultijnck
Anniek Bruggeman
BARBARA VAN RUYMBEKE
Stefanie Mortier
Anneleen Raes
Elke Rammant
Martine De Muynck
Benedicte Deforche
Valerie Fonteyne
Karel Decaestecker
et al.
C3
Conference
2019
Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial
Elke Rammant
Piet Ost
Martijn Swimberghe
Barbara Vanderstraeten
Nicolaas Lumen
Karel Decaestecker
Renée Bultijnck
Gert De Meerleer
Camille Sarrazyn
Roos Colman
et al.
A1
Journal Article
in
STRAHLENTHERAPIE UND ONKOLOGIE
2019
Patient-reported outcomes after stereotactic body radiotherapy in lung cancer: The Lung PLUS study
Lotte van der Weijst
Renée Bultijnck
Axel Van Damme
Marc Van Eijkeren
Veerle Surmont
Yolande Lievens
C3
Conference
2019
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer
Petra Seibold
Adam Webb
Miguel E. Aguado-Barrera
David Azria
Celine Bourgier
Muriel Brengues
Erik Briers
Renée Bultijnck
Patricia Calvo-Crespo
Ana Carballo
et al.
A1
Journal Article
in
Radiotherapy and Oncology
2019
Understanding physical activity behavior in patients with bladder cancer before and after radical cystectomy : a qualitative interview study
Elke Rammant
Valerie Fonteyne
Karel Decaestecker
Renée Bultijnck
Benedicte Deforche
Ronny Pieters
Piet Ost
Sofie Verhaeghe
Ann Van Hecke
A1
Journal Article
in
CLINICAL REHABILITATION
2019
2018
A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy
Elke Rammant
Karel Decaestecker
Renée Bultijnck
Nora Sundahl
Piet Ost
Nele Pauwels
Benedicte Deforche
Ronny Pieters
Valerie Fonteyne
A1
Journal Article
in
CLINICAL REHABILITATION
2018
Availability of prostate cancer exercise rehabilitation resources and practice patterns in Belgium : results of a cross-sectional study
Renée Bultijnck
BARBARA VAN RUYMBEKE
Sofie Everaert
Helena Bagué
Elke Rammant
Steven Rimbaut
Valerie Fonteyne
Nicolaas Lumen
Karel Decaestecker
Piet Ost
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER CARE
2018
Clinical pathway improves implementation of evidence-based strategies for the management of androgen deprivation therapy-induced side effects in men with prostate cancer
Renée Bultijnck
Inge Van de Caveye
Elke Rammant
Sofie Everaert
Nicolaas Lumen
Karel Decaestecker
Valerie Fonteyne
Benedicte Deforche
Piet Ost
A1
Journal Article
in
BJU INTERNATIONAL
2018
Patient-reported outcomes in the search for the optimal radiotherapy schedule for prostate cancer
Elke Rammant
Piet Ost
Martijn Swimberghe
FRANK VANPACHTENBEKE
Renée Bultijnck
Nicolaas Lumen
Karel Decaestecker
Valerie Fonteyne
C3
Conference
2018
Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial
Piet Ost
Dries Reynders
Karel Decaestecker
Valerie Fonteyne
Nicolaas Lumen
Aurélie De Bruycker
Bieke Lambert
Louke Delrue
Renée Bultijnck
Tom Claeys
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2018
2017
Rehabilitation interventions to improve patient-reported outcomes and physical fitness in survivors of muscle invasive bladder cancer : a systematic review protocol
Elke Rammant
Renée Bultijnck
Nora Sundahl
Piet Ost
Nele Pauwels
Benedicte Deforche
Ronny Pieters
Karel Decaestecker
Valerie Fonteyne
A2
Journal Article
in
BMJ OPEN
2017
2016
Practice patterns compared with evidence-based strategies for the management of androgen deprivation therapy-induced side effects in prostate cancer patients : results of a European web-based survey
Renée Bultijnck
Cristian Surcel
Guillaume Ploussard
Alberto Briganti
Pieter De Visschere
Jurgen Fütterer
Pirus Ghadjar
Gianluca Giannarini
Hendrik Isbarn
Christophe Massard
et al.
A1
Journal Article
in
EUROPEAN UROLOGY FOCUS
2016
2015
Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: a 3-arm randomized phase II trial
Dieter Berwouts
Katrien De Wolf
Bieke Lambert
Renée Bultijnck
Wilfried De Neve
Lizzy De Lobel
Lennart Jans
Els Goetghebeur
Bruno Speleers
Ana Maria Luiza Olteanu
et al.
A1
Journal Article
in
RADIOTHERAPY AND ONCOLOGY
2015
Preferences for the management of androgen deprivation-induced osteoporosis and metabolic syndrome in prostate cancer patients: A European web-based survey
Renée Bultijnck
Christian Surcel
Guillaume Ploussard
Alberto Briganti
Pieter De Visschere
Jurgen Fütterer
Pirus Ghadjar
Gianluca Giannarini
Hendrik Isbarn
Christophe Massard
et al.
C3
Conference
2015